Close Menu

Two Cents

The re-opened comment period for feedback to the US Food and Drug Administration on direct-to-consumer genetic testing ends today. The panel focused on molecular and clinical genetics, which is part of the medical devices committee, is seeking “input and comments from interested stakeholders to discuss scientific issues concerning DTC tests,” according to the Federal Register.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.